PL1799201T3 - Żelowe kompozycje 4-hydroksytemoksyfenu - Google Patents

Żelowe kompozycje 4-hydroksytemoksyfenu

Info

Publication number
PL1799201T3
PL1799201T3 PL05803579T PL05803579T PL1799201T3 PL 1799201 T3 PL1799201 T3 PL 1799201T3 PL 05803579 T PL05803579 T PL 05803579T PL 05803579 T PL05803579 T PL 05803579T PL 1799201 T3 PL1799201 T3 PL 1799201T3
Authority
PL
Poland
Prior art keywords
hydroxy tamoxifen
gel formulations
tamoxifen gel
hydroxy
formulations
Prior art date
Application number
PL05803579T
Other languages
English (en)
Inventor
Valérie Masini-Eteve
Original Assignee
Besins Healthcare Lu Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04292447A external-priority patent/EP1647271A1/en
Application filed by Besins Healthcare Lu Sarl filed Critical Besins Healthcare Lu Sarl
Publication of PL1799201T3 publication Critical patent/PL1799201T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
PL05803579T 2004-10-14 2005-10-13 Żelowe kompozycje 4-hydroksytemoksyfenu PL1799201T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04292447A EP1647271A1 (en) 2004-10-14 2004-10-14 4-Hydroxy tamoxifen gel formulations
US63835904P 2004-12-23 2004-12-23
PCT/EP2005/011654 WO2006040196A1 (en) 2004-10-14 2005-10-13 4-hydroxy tamoxifen gel formulations
EP05803579A EP1799201B1 (en) 2004-10-14 2005-10-13 4-hydroxy tamoxifen gel formulations

Publications (1)

Publication Number Publication Date
PL1799201T3 true PL1799201T3 (pl) 2009-05-29

Family

ID=35501209

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05803579T PL1799201T3 (pl) 2004-10-14 2005-10-13 Żelowe kompozycje 4-hydroksytemoksyfenu

Country Status (23)

Country Link
EP (1) EP1799201B1 (pl)
JP (1) JP5047800B2 (pl)
KR (1) KR101294947B1 (pl)
AT (1) ATE415156T1 (pl)
AU (1) AU2005293712B2 (pl)
BR (1) BRPI0518139B1 (pl)
CA (1) CA2582174C (pl)
CY (1) CY1110499T1 (pl)
DE (1) DE602005011314D1 (pl)
DK (1) DK1799201T3 (pl)
EA (1) EA011295B1 (pl)
ES (1) ES2318563T3 (pl)
GE (1) GEP20104889B (pl)
HR (1) HRP20090239T1 (pl)
IL (1) IL182298A (pl)
MA (1) MA28927B1 (pl)
MX (1) MX2007004371A (pl)
NO (1) NO338755B1 (pl)
PL (1) PL1799201T3 (pl)
PT (1) PT1799201E (pl)
SI (1) SI1799201T1 (pl)
TN (1) TNSN07139A1 (pl)
WO (1) WO2006040196A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10080760B2 (en) * 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
KR101304536B1 (ko) * 2011-06-03 2013-09-24 전남대학교산학협력단 4-하이드록시 타목시펜 유사체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 간질환의 치료 또는 예방용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
EP1572178B1 (en) * 2002-12-18 2006-05-03 Laboratoires Besins International Treatment of mastalgia with 4-hydroxy tamoxifen
EP1952809B1 (en) * 2002-12-18 2017-08-02 Besins Healthcare Luxembourg SARL Formulations for the reduction of breast density with 4-Hydroxy Tamoxifen
ES2483896T3 (es) * 2003-04-01 2014-08-08 Besins Healthcare Luxembourg Sarl Prevención y tratamiento de cáncer de seno con 4-hidroxi tamoxifen
JP5069469B2 (ja) * 2003-12-15 2012-11-07 ラボラトワール ブザン アンテルナスィヨナル 女性化乳房治療用の薬剤を製造する際の４−ヒドロキシタモキシフェンの使用
EP1748770B1 (en) * 2004-03-22 2008-04-09 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
US20050208139A1 (en) * 2004-03-22 2005-09-22 Ascend Therapeutics, Inc. Chemically stable compositions of 4-hydroxy tamoxifen
EP1579856A1 (en) * 2004-03-22 2005-09-28 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen

Also Published As

Publication number Publication date
JP5047800B2 (ja) 2012-10-10
DK1799201T3 (da) 2009-03-30
ES2318563T3 (es) 2009-05-01
IL182298A0 (en) 2007-07-24
PT1799201E (pt) 2009-02-26
AU2005293712B2 (en) 2011-04-21
NO338755B1 (no) 2016-10-17
ATE415156T1 (de) 2008-12-15
MX2007004371A (es) 2007-06-07
EA011295B1 (ru) 2009-02-27
MA28927B1 (fr) 2007-10-01
HRP20090239T1 (en) 2009-06-30
GEP20104889B (en) 2010-02-10
HK1103027A1 (en) 2007-12-14
EA200700834A1 (ru) 2007-10-26
TNSN07139A1 (en) 2008-11-21
CA2582174C (en) 2013-01-29
WO2006040196A1 (en) 2006-04-20
EP1799201B1 (en) 2008-11-26
KR20070068366A (ko) 2007-06-29
BRPI0518139B1 (pt) 2021-10-13
JP2008525316A (ja) 2008-07-17
IL182298A (en) 2013-01-31
KR101294947B1 (ko) 2013-08-09
BRPI0518139A (pt) 2008-10-28
CY1110499T1 (el) 2015-04-29
AU2005293712A1 (en) 2006-04-20
SI1799201T1 (sl) 2009-06-30
CA2582174A1 (en) 2006-04-20
DE602005011314D1 (de) 2009-01-08
EP1799201A1 (en) 2007-06-27
NO20072463L (no) 2007-05-14

Similar Documents

Publication Publication Date Title
IL273422A (en) Methods and systems for extracorporeal organ treatment
ATE432067T1 (de) Embolie-teilchen
SE0301653D0 (sv) Novel compounds
NO20091976L (no) Nye forbindelser
NO20092611L (no) Krystallinsk faststoff Rasagilin base
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
TW200738649A (en) Calcilytic compounds
ZA200703016B (en) 4-Hydroxy tamoxifen gel formulations
TW200716088A (en) Formulations and methods for treating amyloidosis
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
AU2003219046A1 (en) Cationic polymers and the use thereof in cosmetic formulations
MXPA05008902A (es) Soluciones de drogas en mentol.
ZA200604874B (en) Pharmaceutical compositions
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
TNSN07139A1 (en) 4-hydroxy tamoxifen gel formulations
DE602005009681D1 (de) Haarbehandlungszusammensetzungen mit einem disaccharid; einer disäure und einer ammoniumionen-quelle
EA200700023A1 (ru) Разрыхляющаяся при пероральном приёме фармацевтическая композиция, содержащая рисперидон
TW200505460A (en) Rosmarinic acid composition
TW200511987A (en) Topical composition
MX2009009178A (es) Bis-fosforatos de bazedoxifeno.
EA200700580A1 (ru) Тестостероновые гели, включающие пропиленгликоль в качестве усилителя проницаемости
ATE425212T1 (de) Tocopherolzusammensetzungen und verwendung
ITRM20020358A0 (it) Composizione estetico-farmaceutica per applicazione topica, procedimento per la sua produzione e suoi impieghi.
BRPI0501052A (pt) composição cosmética à base de papaìna
UA62577C2 (en) Pollentar, pharmaceutical adaptogenic composition